Pharmaceutical

Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

May 1, 2024 - 00:00
Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.
Read the original article

Tags:

Previous Article

Ionis Pharmaceuticals gets grant for modified oligonucleotide for reducing lRRK2...

Next Article

Corcept Therapeutics gets grant for method of preparing compound of formula i

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BARDA and Tiba Biotech link to develop ‘flu therapeutics

BARDA and Tiba Biotech link to develop ‘flu therapeutics

Jul 12, 2024

Sanofi and AstraZeneca to supply additional RSV doses to US

Sanofi and AstraZeneca to supply additional RSV doses t...

Dec 16, 2023

STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?

STAT+: Novo’s Catalent deal is great for GLP-1s. But wh...

Feb 5, 2024